Cargando…

Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet

The process of understanding the control and capability (PUCC) is an iterative closed loop process for continuous improvement. It covers the DMAIC toolkit in its three phases. PUCC is an iterative approach that rotates between the three pillars of the process of understanding, process control, and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chabukswar, AR, Jagdale, SC, Kuchekar, BS, Joshi, VD, Deshmukh, GR, Kothawade, HS, Kuckekar, AB, Lokhande, PD
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094555/
https://www.ncbi.nlm.nih.gov/pubmed/21607050
http://dx.doi.org/10.4103/0975-1483.76415
_version_ 1782203580857450496
author Chabukswar, AR
Jagdale, SC
Kuchekar, BS
Joshi, VD
Deshmukh, GR
Kothawade, HS
Kuckekar, AB
Lokhande, PD
author_facet Chabukswar, AR
Jagdale, SC
Kuchekar, BS
Joshi, VD
Deshmukh, GR
Kothawade, HS
Kuckekar, AB
Lokhande, PD
author_sort Chabukswar, AR
collection PubMed
description The process of understanding the control and capability (PUCC) is an iterative closed loop process for continuous improvement. It covers the DMAIC toolkit in its three phases. PUCC is an iterative approach that rotates between the three pillars of the process of understanding, process control, and process capability, with each iteration resulting in a more capable and robust process. It is rightly said that being at the top is a marathon and not a sprint. The objective of the six sigma study of Ranitidine hydrochloride tablets is to achieve perfection in tablet manufacturing by reviewing the present robust manufacturing process, to find out ways to improve and modify the process, which will yield tablets that are defect-free and will give more customer satisfaction. The application of six sigma led to an improved process capability, due to the improved sigma level of the process from 1.5 to 4, a higher yield, due to reduced variation and reduction of thick tablets, reduction in packing line stoppages, reduction in re-work by 50%, a more standardized process, with smooth flow and change in coating suspension reconstitution level (8%w/w), a huge cost reduction of approximately Rs.90 to 95 lakhs per annum, an improved overall efficiency by 30% approximately, and improved overall quality of the product.
format Text
id pubmed-3094555
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30945552011-05-23 Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet Chabukswar, AR Jagdale, SC Kuchekar, BS Joshi, VD Deshmukh, GR Kothawade, HS Kuckekar, AB Lokhande, PD J Young Pharm Pharmaceutics The process of understanding the control and capability (PUCC) is an iterative closed loop process for continuous improvement. It covers the DMAIC toolkit in its three phases. PUCC is an iterative approach that rotates between the three pillars of the process of understanding, process control, and process capability, with each iteration resulting in a more capable and robust process. It is rightly said that being at the top is a marathon and not a sprint. The objective of the six sigma study of Ranitidine hydrochloride tablets is to achieve perfection in tablet manufacturing by reviewing the present robust manufacturing process, to find out ways to improve and modify the process, which will yield tablets that are defect-free and will give more customer satisfaction. The application of six sigma led to an improved process capability, due to the improved sigma level of the process from 1.5 to 4, a higher yield, due to reduced variation and reduction of thick tablets, reduction in packing line stoppages, reduction in re-work by 50%, a more standardized process, with smooth flow and change in coating suspension reconstitution level (8%w/w), a huge cost reduction of approximately Rs.90 to 95 lakhs per annum, an improved overall efficiency by 30% approximately, and improved overall quality of the product. Medknow Publications 2011 /pmc/articles/PMC3094555/ /pubmed/21607050 http://dx.doi.org/10.4103/0975-1483.76415 Text en © Journal of Young Pharmacists http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pharmaceutics
Chabukswar, AR
Jagdale, SC
Kuchekar, BS
Joshi, VD
Deshmukh, GR
Kothawade, HS
Kuckekar, AB
Lokhande, PD
Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet
title Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet
title_full Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet
title_fullStr Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet
title_full_unstemmed Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet
title_short Six Sigma: Process of Understanding the Control and Capability of Ranitidine Hydrochloride Tablet
title_sort six sigma: process of understanding the control and capability of ranitidine hydrochloride tablet
topic Pharmaceutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094555/
https://www.ncbi.nlm.nih.gov/pubmed/21607050
http://dx.doi.org/10.4103/0975-1483.76415
work_keys_str_mv AT chabukswarar sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet
AT jagdalesc sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet
AT kuchekarbs sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet
AT joshivd sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet
AT deshmukhgr sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet
AT kothawadehs sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet
AT kuckekarab sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet
AT lokhandepd sixsigmaprocessofunderstandingthecontrolandcapabilityofranitidinehydrochloridetablet